drugset / Trial / NCT00913107

Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

NCT00913107

Phase 2/3 Completed 21 enrolled University of Malaya
Non-randomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study was to determine the efficacy and safety of lamotrigine in patients with trigeminal neuralgia (TGN).

Timeline

Start
2007-09
Primary completion
2008-02
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule 300 mg
Subject Lamotrigine Small molecule 100 mg

Indications